Gara Jalqabaatti › Atrophy Geographica
Qorannoo klinikaalii Atrophy Geographica Ameerikaa Keessatti hirmaatuu
Qorannoo 24 Atrophy Geographica f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
- Reno, NVQorannoo 8
- Dallas, TXQorannoo 8
- Austin, TXQorannoo 7
- Santa Monica, CAQorannoo 7
- Naperville, ILQorannoo 6
- Cleveland, OHQorannoo 6
- The Woodlands, TXQorannoo 6
- Baltimore, MDQorannoo 6
- Houston, TXQorannoo 6
- St. Louis, MOQorannoo 5
- Washington, DCQorannoo 5
- Erie, PAQorannoo 5
- San Antonio, TXQorannoo 5
- Sacramento, CAQorannoo 5
- Spokane, WAQorannoo 5
- Hagerstown, MDQorannoo 5
- Fort Worth, TXQorannoo 4
- St. Petersburg, FLQorannoo 4
- Nashville, TNQorannoo 4
- Philadelphia, PAQorannoo 4
- Raleigh, NCQorannoo 4
- Lynchburg, VAQorannoo 4
- Durham, NCQorannoo 4
- Escondido, CAQorannoo 3
- Salt Lake City, UTQorannoo 3
- San Francisco, CAQorannoo 3
- Mountain View, CAQorannoo 3
- Huntington Beach, CAQorannoo 3
- Cincinnati, OHQorannoo 3
- Sarasota, FLQorannoo 3
- Boston, MAQorannoo 3
- Lewisville, TXQorannoo 3
- Allentown, PAQorannoo 3
- Abilene, TXQorannoo 3
- Eugene, ORQorannoo 3
- McAllen, TXQorannoo 3
- Phoenix, AZQorannoo 3
- Los Angeles, CAQorannoo 3
- Syracuse, NYQorannoo 3
- Concord, CAQorannoo 3
Naannoon
- ArizonaQorannoo 5
- CaliforniaQorannoo 13
- ColoradoQorannoo 4
- ConnecticutQorannoo 4
- FloridaQorannoo 8
- GeorgiaQorannoo 4
- IllinoisQorannoo 9
- IndianaQorannoo 3
- MarylandQorannoo 7
- MassachusettsQorannoo 7
- MichiganQorannoo 5
- MississippiQorannoo 3
- MissouriQorannoo 5
- NevadaQorannoo 8
- New JerseyQorannoo 3
- New YorkQorannoo 4
- North CarolinaQorannoo 7
- OhioQorannoo 7
- OregonQorannoo 4
- PennsylvaniaQorannoo 9
- South CarolinaQorannoo 4
- TennesseeQorannoo 4
- TexasQorannoo 15
- UtahQorannoo 4
- VirginiaQorannoo 4
- WashingtonQorannoo 6
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 55 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06659549A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Namoota walitti qabaa jiraSadarkaa 2/3
Umuriin 60 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT06635148Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated With Age-Related Macular Degeneration
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 55 hanga 95 · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT04339764A Phase IIb Randomized, Multicenter Trial of Subretinal CPCB-RPE1 in Advanced Dry AMD (Geographic Atrophy)
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 55 hanga 90 · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT06557460A Phase 1/2 Study of the Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 55 fi ol · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT07029945A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 60 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07215234A Study in Adults With Geographic Atrophy
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 60 fi ol · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT07606365A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 50 hanga 85 · Saalaa hunda · Haaromfame 18-Ful-2026 · NCT06541704A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 50 fi ol · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT05626114Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 55 fi ol · Saalaa hunda · Haaromfame 10-Ful-2026 · NCT06659445A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 55 fi ol · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT07144137A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 50 fi ol · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT03178149Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration
Namoota walitti qabaa jira
Umuriin 60 fi ol · Saalaa hunda · Haaromfame 26-Hag-2026 · NCT06662162SGLT2 Inhibitors in Geographic Atrophy
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 50 fi ol · Saalaa hunda · Haaromfame 26-Hag-2026 · NCT07174687Phase 1 Study of C.001 in Retinal Degeneration
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Hag-2026 · NCT07594236Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 50 fi ol · Saalaa hunda · Haaromfame 05-Hag-2026 · NCT07230834Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 50 fi ol · Saalaa hunda · Haaromfame 13-Ado-2026 · NCT07160179Stem Cell Ophthalmology Treatment Study II
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Wax-2026 · NCT03011541High Resolution Retinal Imaging
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 7 fi ol · Saalaa hunda · Haaromfame 05-Cam-2026 · NCT01866371Central micrOperimetry and Radial OCT Evaluation in Geographic Atrophy (CORE-GA): a Prospective Pilot Study
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 55 fi ol · Saalaa hunda · Haaromfame 29-Elb-2026 · NCT07556406Progression of Early Atrophic Lesions
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 50 fi ol · Saalaa hunda · Haaromfame 11-Bit-2026 · NCT05959005A Phase 1/2 Study to Evaluate the Safety and Efficacy of Intravitreal Administration of BS01 in Patients With Geographic Atrophy Secondary to Dry AMD
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 50 hanga 85 · Saalaa hunda · Haaromfame 23-Ama-2026 · NCT07158775A Prospective Observational Study to Assess the Reliability and Validity of the MLSDT
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Bit-2025 · NCT06805474Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
Namoota walitti qabaa jira
Umuriin 65 fi ol · Saalaa hunda · Haaromfame 03-Mud-2024 · NCT05438732Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.